Cargando…
Handbook of HER2-targeted agents in breast cancer
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15-25% overexpress HER2, a transmembrane RTK kinase that is associated with aggress...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Autor Corporativo: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Tarporley :
Springer Healthcare Ltd. : Imprint: Springer Healthcare,
2013.
|
| Edición: | 1st ed. 2013. |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-1-907673-94-8 | ||
| 003 | DE-He213 | ||
| 005 | 20220116021236.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 140528s2013 xxk| s |||| 0|eng d | ||
| 020 | |a 9781907673948 |9 978-1-907673-94-8 | ||
| 024 | 7 | |a 10.1007/978-1-907673-94-8 |2 doi | |
| 050 | 4 | |a RC254-282 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 616.994 |2 23 |
| 100 | 1 | |a Alvarez, Ricardo H. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 245 | 1 | 0 | |a Handbook of HER2-targeted agents in breast cancer |h [electronic resource] / |c by Ricardo H Alvarez, Javier Cortés, Leticia Mattos-Arruda, Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart, Stefania Zambelli, Dimitrios Zardavas. |
| 250 | |a 1st ed. 2013. | ||
| 264 | 1 | |a Tarporley : |b Springer Healthcare Ltd. : |b Imprint: Springer Healthcare, |c 2013. | |
| 300 | |a XI, 96 p. 13 illus. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Introduction and background biology -- HER2 testing -- HER2-positive breast cancer: adjuvant and neoadjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer. | |
| 520 | |a Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15-25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes. However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer provides oncologists, primary care physicians, trainees and other healthcare providers with a concise, accessible, and up-to-date survey of the field, including a review of our current understanding of the biology of the HER2 pathway and the rationale for targeting it in early-stage and advanced breast cancer, an overview of HER2-testing, and evidence-based discussions of available HER2-targeted regimens in the adjuvant and metastatic settings. | ||
| 650 | 0 | |a Oncology. | |
| 650 | 0 | |a Primary care (Medicine). | |
| 650 | 0 | |a Family medicine. | |
| 650 | 0 | |a Internal medicine. | |
| 650 | 0 | |a Therapeutics. | |
| 650 | 1 | 4 | |a Oncology. |
| 650 | 2 | 4 | |a Primary Care Medicine. |
| 650 | 2 | 4 | |a General Practice and Family Medicine. |
| 650 | 2 | 4 | |a Internal Medicine. |
| 650 | 2 | 4 | |a Therapeutics. |
| 700 | 1 | |a Cortés, Javier. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Mattos-Arruda, Leticia. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Falzon, Mary. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Fasolo, Angelica. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Gandy, Michael. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Gianni, Luca. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Harbeck, Nadia. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Piccart, Martine. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Zambelli, Stefania. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 700 | 1 | |a Zardavas, Dimitrios. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781907673931 |
| 776 | 0 | 8 | |i Printed edition: |z 9781907673955 |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-1-907673-94-8 |z Texto Completo |
| 912 | |a ZDB-2-SME | ||
| 912 | |a ZDB-2-SXM | ||
| 950 | |a Medicine (SpringerNature-11650) | ||
| 950 | |a Medicine (R0) (SpringerNature-43714) | ||